Inventor

Michael M. Morrissey

Inventor
Danville, CA, US

Overview

72→
Patents
1995–2014
Patent span
Chemistry
Primary field (CPC C)

Patents· 72 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds41%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations38%
A61KPreparations for medical, dental or toiletry purposes9%
C07CAcyclic or carbocyclic compounds7%
B01JChemical or physical processes, e.g. catalysis or colloid chemistry1%
C40BCombinatorial chemistry1%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests1%
Y10TTechnical subjects covered by former us classification1%
PatentTitleYear
8,846,739'TGR5 agonists'20148,785,488'Triazole and imidazole derivatives for use as TGR5 agonists in the treatment of diabetes and obesity'20147,268,140'Piperazine derivatives and their use as anti-inflammatory agents'20077,176,207'Platelet adenosine diphosphate receptor antagonists'20077,084,142'Platelet adenosine diphosphate receptor antagonists'20067,056,923'Platelet adenosine diphosphate receptor antagonists'20067,026,323'Platelet adenosine diphosphate receptor antagonists'20066,995,156'Platelet adenosine diphosphate receptor antagonists'20066,977,258'Piperazine derivatives and their use as anti-inflammatory agents'20056,972,290'Piperazine derivatives and their use as anti-inflammatory agents'20056,887,865'N-heterocyclic derivatives as NOS inhibitors'20056,864,368'N-heterocyclic derivatives as NOS inhibitors'20056,864,263'N-heterocyclic derivatives as NOS inhibitors'20056,861,424'Platelet adenosine diphosphate receptor antagonists'20056,849,739'N-heterocyclic derivatives as NOS inhibitors'20056,846,829'N-heterocyclic derivatives as NOS inhibitors'20056,841,673'N-heterocyclic derivatives as nos inhibitors'20056,841,674'N-heterocyclic derivatives as NOS inhibitors'20056,747,031'N-heterocyclic derivatives as NOS inhibitors'20046,686,364'Benzamidine derivatives and their use as anti-coagulants'20046,670,473'N-heterocyclic derivatives as NOS inhibitors'20036,573,266'Piperazine derivatives and their use as anti-inflammatory agents'20036,555,537'Piperazine derivatives and their use as anti-inflammatory agents'20036,541,476'Piperazine derivatives and their use as anti-inflammatory agents'20036,534,509'Piperazine derivatives and their use as anti-inflammatory agents'20036,498,185'Ortho-anthranilamide derivatives as anti-coagulants'20026,479,485'Benzamidine derivatives and their use as anti-coagulants'20026,465,459'Benzamidine derivatives and their use as anti-coagulants'20026,432,947'N-heterocyclic derivatives as NOS inhibitors'20026,380,221'Ortho-anthranilamide derivatives as anti-coagulants'20026,350,746'Benzamidine derivatives and their use as anti-coagulants'20026,306,884'Benzamidine derivatives and their use as anti-coagulants'20016,274,091'Apparatus and process for multiple chemical reactions'20016,265,404'Benzamidine derivatives substituted by cyclic amino acid and cyclic hydroxy acid derivatives and their use as anti-coagulants'20016,242,454'Benzamidine derivatives substituted by amino acid and hydroxy acid derivatives and their use as anti-coagulants'20016,232,325'Benzamidine derivatives substituted by cyclic amino acid and cyclic hydroxy acid derivatves and their use as anti-coagulants'20016,221,886'Thio acid derived monocyclic N-heterocyclics as anticoagulants'20016,207,665'Piperazine derivatives and their use as anti-inflammatory agents'20016,177,473'Benzamidine derivatives substituted by cyclic amino acid and cyclic hydroxy acid derivatives and their use as anti-coagulants'20016,166,088'Benzamidine derivatives substituted by amino acid and hydroxy acid derivatives and their use as anti-coagulants'20006,166,014'Thio acid derived monocyclic N-heterocyclics as anticoagulants'20006,162,807'Thio acid derived monocyclic N-heterocyclics as anticoagulants'20006,150,382'Thio acid derived monocyclic n-heterocyclics as anticoagulants'20006,140,351'Ortho-anthranilamide derivatives as anti-coagulants'20006,071,912'Benzamidine derivatives substituted by amino acid and hydroxy acid derivatives and their use as anti-coagulants'20006,034,103'Benzamidine derivatives and their use as anti-coagulants'20006,034,084'Thio acid derived monocyclic N-heterocyclics as anticoagulants'20006,008,234'Benzamidine derivatives substituted by cyclic amino acid and cyclic hydroxy acid derivatives and their use as anti-coagulants'19996,004,981'Benzamidine derivatives and their use as anti-coagulants'19996,004,985'Thio acid derived monocylic N-heterocyclics as anticoagulants'19995,994,375'Benzamidine derivatives substituted by amino acid and hydroxy acid derivatives and their use as anti-coagulants'19995,888,830'Apparatus and process for multiple chemical reactions'19995,889,005'Benzamidine derivatives and their use for treating thrombotic diseases'19995,883,100'Benzamidine derivatives and their use as anti-coagulants'19995,877,181'Benzamidine derivatives and their use as anti-coagulants'19995,863,914'N,N-di(aryl) cyclic urea derivatives as anti-coagulants'19995,859,005'N,N-di(aryl) cyclic urea derivatives as anti-coagulants'19995,846,970'Bicyclic pyrimidine derivatives and their use as anti-coagulants'19985,846,972'Bicyclic pyrimidine derivatives and their use as anti-coagulants'19985,753,635'Purine derivatives and their use as anti-coagulants'19985,731,311'N,N-di(aryl) cyclic urea derivatives as anti-coagulants'19985,731,308'N,N-di(aryl) cyclic urea derivatives as anti-coagulants'19985,728,697'N,N-di(aryl) cyclic urea derivatives as anti-coagulants'19985,726,173'N.N-di (aryl) cyclic urea derivatives as anti-coagulants'19985,726,198'N,N-di(aryl) cyclic urea derivatives as anti-coagulants'19985,693,641'Bicyclic pyrimidine derivatives and their use as anti-coagulants'19975,691,364'Benzamidine derivatives and their use as anti-coagulants'19975,639,768'Substituted amidino compounds, their manufacture and methods of treatment'19975,633,381'(Z,Z), (Z,E) and (E,Z) isomers of substituted bis(phenylmethylene)cycloketones'19975,612,363'N,N-di(aryl) cyclic urea derivatives as anti-coagulants'19975,488,160'Amidino compounds, their manufacture and method of treatment'19965,451,700'Amidino compounds, their manufacture and methods of treatment'1995

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1995–1997Patents assigned to CIBA GEIGY CORP (3)· patent assignee history
1995–2014Based in Danville, CA, US· patent location history
1997–2005Patents assigned to BERLEX LAB (50)· patent assignee history
1998–1999Based in Richmond, CA, US· patent location history
2001–2007Patents assigned to SCHERING AG (14)· patent assignee history
2002–2005Patents assigned to PHARMACOPEIA INC (4)· patent assignee history
2005Patents assigned to PHARMACOPEIA DRUG DISCOVERY (6)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
BERLEX LAB501997–2005
SCHERING AG142001–2007
PHARMACOPEIA DRUG DISCOVERY62005
PHARMACOPEIA INC42002–2005
CIBA GEIGY CORP31995–1997
Locations
LocationPatentsSpan
Danville, California, US701995–2014
Richmond, California, US21998–1999